Stimulation of Sigma‐1 Receptor Protects against Cardiac Fibrosis by Alleviating IRE1 Pathway and Autophagy Impairment

Abstract

Sigma-1 receptor (Sig1R), a chaperone in the endoplasmic reticulum (ER) membrane, has been implicated in cardiac hypertrophy; however, its role in cardiac fibroblast activation has not been established. This study investigated the possible association between Sig1R and this activation by subjecting mice to sham, transverse aortic constriction (TAC), and TAC plus fluvoxamine (an agonist of Sig1R) treatments. Cardiac function and fibrosis were evaluated four weeks later by echocardiography and histological staining. In an in vitro study, neonatal rat cardiac fibroblasts were treated with fluvoxamine or NE-100 (an antagonist of Sig1R) in the presence or absence of transforming growth factor beta1 (TGF-β1). Fibrotic markers, ER stress pathways, and autophagy were then investigated by qPCR, western blotting, immunofluorescence, confocal microscopy, and transmission electron microscopy. Fluvoxamine treatment reduced cardiac fibrosis, preserved cardiac function, and attenuated cardiac fibroblast activation. Inhibition of the IRE1/XBP1 pathway, a branch of ER stress, by a specific inhibitor of IRE1 endonuclease activity, attenuated the pathological process. Fluvoxamine stimulation of Sig1R restored autophagic flux in cardiac fibroblasts, indicating that Sig1R appears to play a protective role in the activation of cardiac fibroblasts by inhibiting the IRE1 pathway and restoring autophagic flux. Sig1R may therefore represent a therapeutic target for cardiac fibrosis.

Homocysteine promotes cardiac fibrosis by regulating the Akt/FoxO3 pathway

“…Defective autophagy results in development of heart failure (37), however the role of autophagy in CFs is less known. Recent evidence indicated that autophagic f l u x w a s i m p a i r e d i n a c t i v a t e d C F s a n d f i b r o t i c hearts (38). Another study found that autophagy enhanced the activation of CFs and exerted a profibrotic role (39).…”

Coronavirus Usurps the Autophagy-Lysosome Pathway and Induces Membranes Rearrangement for Infection and Pathogenesis

“…Therefore, the ER-Golgi is another important way to produce DMVs independent of the autophagy pathway. There is substantial evidence that CoVs induce membrane rearrangement by hijacking the host cell ERAD machinery ( Miller et al, 2020 ; Qu et al, 2021 ). NSPs regulate ER and Golgi apparatus rearrangement to form DMVs directly from the ER ( Gassen et al, 2019 ).…”

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy

“…Autophagy dysregulation is known as a key component of several neurodegenerative diseases including Alzheimer’s disease [ 47 ] and in recent years the sigma-1 receptor has been shown to be a target that can directly and indirectly affect autophagy as well as other cellular mechanisms that could be involved in neurodegeneration [ 48 ]. Recent research has shown that sigma-1 receptor stimulation using fluvoxamine activates autophagy and protects against cardiac fibrosis by inhibiting the IRE1 pathway [ 49 ].…”